SCOPE of Pain can be used to count toward the DEA licensure 8-hour training requirement as noted in their 3/27/2023 communication as it aligns with SAMHSA's content recommendations required by the 2022 Medication Access and Training Expansion (MATE) Act.
These 2½- to 3-hour meetings will address the core SCOPE of Pain content, and often include additional content specific to the municipality, region, state, and/or institution serving as collaborating partner.GET STARTED NOW! Select a conference
Daniel P. Alford, MD, MPH
Professor of Medicine
Associate Dean, Continuing Medical Education
Boston University Chobanian & Avedisian School of Medicine
SCOPE of Pain is a continuing medical education/continuing nursing education activity designed to help you safely and effectively manage patients with acute and/or chronic pain, when appropriate, with opioid analgesics. Through the case of Michelle Jones, a 36-year-old who has a displaced right femoral neck fracture due to a motor vehicle crash, you'll learn how to:
Physicians, nurse practitioners, registered nurses, physician assistants, nurses, dentists, pharmacists, and allied health professionals whose practices manage acute and chronic pain.
This activity was planned in collaboration with the Federation of State Medical Boards.
Credit hours will vary depending upon the length of the meeting. Please see registration page for maximum credit amounts.
In support of improving patient care, Boston University Chobanian & Avedisian School of Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
These live activities have been approved for AMA PRA Category 1 Credit™.
The AAFP has reviewed SCOPE of Pain: Safer/Competent Opioid Prescribing Education, and deemed it acceptable for AAFP credit. Term of approval is from 10/18/2022 – 9/21/2023. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Credit approval includes the following session(s):
AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 credit(s)™ toward the AMA Physician's Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.
Continuing Pharmacy Education Information The University of Rhode Island, College of Pharmacy, is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Completion of the entire online program and completion of online evaluations and self-assessment tools at the conclusion of the program are required for reporting continuing education credit to the National Association of Boards of Pharmacy via the CPE Monitor. This is a knowledge based learning activity.
Universal activity number: 0060-9999-21-045-L08-P
This activity is supported by an independent educational grant from the Opioid Analgesic REMS Program Companies. Please see https://opioidanalgesicrems.com/Resources/Docs/List_of_RPC_Companies.pdf for a listing of REMS Program Companies. This activity is intended to be fully compliant with the Opioid Analgesic REMS education requirements issued by the U.S. Food and Drug Administration (FDA).
SCOPE of Pain
© 2023 Trustees of Boston University. Site by Root802.